X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
LUPIN LIMITED Fact Sheet - Equitymaster
Investing in India? Get Equitymaster Research  

LUPIN LIMITED  (LUPL)


Here is the latest financial fact sheet of Lupin Ltd. For more details, see the Lupin Ltd quarterly results and Lupin Ltd share price and chart. For a sector overview, read our pharmaceuticals sector report.
 
lupin ltd - 1 Year Stock Price Chart
Loading...

 Price History
    Price Rs 1,355.0       No. of shares m 451.14
    Mkt Cap Rs m 611,293       % ch % -1.2
    Vol '000 42.6       % ch week % -4.0
    P/E X 20.5       % ch 1-mth % -7.4
    P/CF X 22.3       % ch 12-mth % -14.1
    EPS (TTM) Rs 66.2       52 week H/L Rs 1,750.0/1,355.0
(As on Apr 27, 2017 12:37:00 PM) »  Best Performing pharmaceuticals Stocks

Excel EXPORT | DO YOU LIKE THESE FACTSHEETS? TELL US!
 Financials

* Results Consolidated
No. of Months
Year Ending
12
Mar-12
*
12
Mar-13
*
12
Mar-14
*
12
Mar-15
*
12
Mar-16
*
5-Yr Chart
Click to enlarge
  EQUITY SHARE DATA
High Rs5336391,0032,0372,127 
Low Rs4055076069041,294 
Sales per share (Unadj.) Rs158.6215.4251.7280.3304.1 
Earnings per share (Unadj.) Rs19.429.441.053.550.4 
Diluted earnings per shareRs19.229.140.753.350.3 
Cash flow per share (Unadj.) Rs24.536.846.863.160.7 
Dividends per share (Unadj.) Rs3.204.006.007.507.50 
Adj. dividends per shareRs3.173.975.967.477.49 
Dividend yield (eoy) %0.70.70.70.50.4 
Book value per share (Unadj.) Rs89.8116.3154.6197.4243.8 
Adj. book value per shareRs89.0115.4153.6196.7243.5 
Shares outstanding (eoy) m446.64447.53448.38449.49450.58 
Bonus/Rights/Conversions  ESOP-ESOPESOP- 
Price / Sales ratio x3.02.73.25.25.6 
Avg P/E ratio x24.119.519.627.533.9 
P/CF ratio (eoy) x19.115.617.223.328.2 
Price / Book Value ratio x5.24.95.27.47.0 
Dividend payout %16.513.614.614.014.9 
Avg Mkt Cap Rs m209,474256,435360,767660,975770,740 
No. of employees `000NANANA14.216.4 
Total wages/salary Rs m9,69512,66614,64717,47321,077 
Avg. sales/employee Rs ThNMNMNM8,874.38,379.6 
Avg. wages/employee Rs ThNMNMNM1,230.71,289.0 
Avg. net profit/employee Rs ThNMNMNM1,692.71,388.7 
  INCOME DATA
Net Sales Rs m70,82996,413112,866125,997137,016 
Other income Rs m1442791,1652,3981,877 
Total revenues Rs m70,97396,692114,031128,395138,893 
Gross profit Rs m14,44722,70030,02836,19637,535 
Depreciation Rs m2,2753,3222,6104,3474,635 
Interest Rs m35541026798446 
Profit before tax Rs m11,96119,24628,31734,14834,330 
Minority Interest Rs m-199-263-331-412-88 
Prior Period Items Rs m20000 
Extraordinary Inc (Exp) Rs m00000 
Tax Rs m3,0875,8429,6229,70411,536 
Profit after tax Rs m8,67713,14218,36424,03222,707 
Gross profit margin %20.423.526.628.727.4 
Effective tax rate %25.830.434.028.433.6 
Net profit margin %12.213.616.319.116.6 
  BALANCE SHEET DATA
Current assets Rs m43,42351,43161,00578,32497,790 
Current liabilities Rs m31,20330,06926,29637,29253,872 
Net working cap to sales %17.322.230.832.632.1 
Current ratio x1.41.72.32.11.8 
Inventory Days Days8974697385 
Debtors Days Days92838077121 
Net fixed assets Rs m26,89428,03630,01932,96186,379 
Share capital Rs m893895897899901 
"Free" reserves Rs m37,65649,55467,92285,830105,735 
Net worth Rs m40,12952,04269,31688,741109,844 
Long term debt Rs m4,3302,4711,5101,01853,739 
Total assets Rs m79,35489,139102,060131,377224,378 
Interest coverage x34.747.9107.3349.177.9 
Debt to equity ratio x0.10000.5 
Sales to assets ratio x0.91.11.11.00.6 
Return on assets %11.415.218.318.410.3 
Return on equity %21.625.326.527.120.7 
Return on capital %27.335.639.937.721.2 
Exports to sales %42.844.850.746.449.1 
Imports to sales %10.78.78.68.87.4 
Exports (fob) Rs m30,32943,15757,17758,48267,244 
Imports (cif) Rs m7,6088,3919,65411,05710,199 
Fx inflow Rs m32,44444,74963,07662,59371,405 
Fx outflow Rs m11,38913,82016,48016,59217,807 
Net fx Rs m21,05530,92946,59646,00153,598 
  CASH FLOW
From Operations Rs m 5,600 12,510 20,039 27,331 -3,690 
From Investments Rs m -7,413 -5,219 -8,585 -10,545 -69,434 
From Financial Activity Rs m 1,089 -6,628 -8,571 -1,969 58,126 
Net Cashflow Rs m -724 663 2,883 14,817 -14,998 
* Results Consolidated Source: Company Annual Reports, Regulatory Filings, Equitymaster »  Historical quarterly results for lupin limited

 Share Holding
Indian Promoters : 46.6%
Foreign collaborators : 0.2%
Indian inst/Mut Fund : 11.3%
FIIs : 31.9%
ADR/GDR : 0.0%
Free float : 10.1%
Shareholders : 98,259
Pledged promoter(s) holding : 0.0%
 Company Information
Top
    REGD OFF: 159, C.S.T. Road, Kalina, Santacruz (E), Mumbai - 400 098
    E-MAIL: rajvardhansatam@lupinpharma.com     WEB: www.lupinworld.com
    TELEPHONE: (022) 6640 2323     FAX: (022) 2652 8806
    SECTOR: PHARMACEUTICALS     GROUP: MISCELLANEOUS
    TR AGENT: In-house
    AUDITOR: Deloitte Haskins & Sells
CHM: D. B. Gupta COMP SEC: R. V. Satam YEAR OF INC: 1983 BSE CODE: 500257 FV (Rs): 2 DIV YIELD (%): 0.6

More pharmaceuticals Company Fact Sheets:   ELDER PHARMACIPLAAJANTA PHARMAINDOCO REMEDIESDISHMAN PHARMA


Today's Market

Indian Indices Trade Marginally Lower; IT Stocks Witness Buying(11:30 am)

After opening the day on a flat note, share markets in India continued to trade near the dotted line and are presently trading marginally lower. Sectoral indices are trading on a mixed note with stocks.

Views on news

Lupin: US Business Drives Growth (Quarterly Results Update - Detailed)

Mar 8, 2017

Lupin has announced its 3QFY17 results. Net sales have grown by 31.5% YoY and net profits have surged by 20.7% YoY. Here is our analysis of the results.

Lupin: Key Products Drive US growth (Quarterly Results Update - Detailed)

Sep 12, 2016

Lupin has announced its 1QFY17results. Net sales have grown by 40% YoY and net profits have surged by 55.1% YoY. Here is our analysis of the results.

Lupin: Niche products boost business growth (Quarterly Results Update - Detailed)

Jun 15, 2016

Lupin has announced its 4QFY16 results. Net sales have grown by 38.6% YoY, while net profits declined by 54.8% YoY. Here is our analysis of the results.

Sun Pharma: Slow Growth Across Major Markets (Quarterly Results Update - Detailed)

Mar 11, 2017

Sun Pharma has announced its December quarter (3QFY17) results. The company has reported 8% YoY growth in sales and a decline of 4.7% YoY in the net profits.

Cipla: Operating Margins Improve (Quarterly Results Update - Detailed)

Mar 8, 2017

Cipla has announced its results for the December quarter (1QFY17) results. The company has reported a decline of 6.4% YoY in sales while profits were down by 43.7% YoY.

More Views on News

Most Popular

Our Private Class with India's Value Investing Guru(The 5 Minute Wrapup)

Apr 19, 2017

Rohan and Kunal present you the discussions with professor Sanjay Bakshi in his virtual classroom.

HDFC Bank: The Solid Outperformer(Chart Of The Day)

Apr 22, 2017

Why HDFC Bank beat the Sensex by nearly 3 times.

The Real Reason Indiabulls Real Estate Jumped 42%(Daily Profit Hunter)

Apr 19, 2017

An elephant and six blind men will tell you more about the markets than any financial newspaper or channel.

In an Ocean of Corporate Defaulters, Vijay Mallya is a Small Fish(Vivek Kaul's Diary)

Apr 20, 2017

While it is important to get Mallya back to India, the government needs to show the same vigour in chasing defaulters of public sector bank loans residing in India.

4 Ways GST Will Impact The Mutual Fund Industry(Outside View)

Apr 19, 2017

PersonalFN explains how GST would impact India's mutual fund industry and investors

More

TRACK LUPIN LTD

  • Track your investment in LUPIN LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON LUPIN LTD

LUPIN LTD - AJANTA PHARMA COMPARISON

Compare Company With Charts

COMPARE LUPIN LTD WITH

MARKET STATS